US Stock MarketDetailed Quotes

ATAI ATAI Life Sciences

Watchlist
  • 1.470
  • -0.030-2.00%
Close May 5 16:00 ET
  • 1.490
  • +0.020+1.36%
Post 20:01 ET
293.70MMarket Cap-1.58P/E (TTM)

ATAI Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.00%-82.44M
-10.62%-24.3M
-4.94%-19.34M
28.24%-16.23M
-6.93%-22.57M
19.48%-84.12M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
Net income from continuing operations
-241.84%-150.05M
-103.69%-38.99M
-160.66%-26.31M
-69.87%-57.37M
20.31%-27.38M
72.12%-43.9M
58.97%-19.14M
221.49%43.37M
9.96%-33.77M
8.53%-34.35M
Operating gains losses
-55.86%1.91M
21.28%701K
-1,828.57%-810K
-93.47%126K
1.61%1.9M
-54.74%4.33M
-87.10%578K
98.03%-42K
-38.62%1.93M
-54.26%1.87M
Depreciation and amortization
48.28%473K
122.77%225K
12.16%83K
3.80%82K
27.69%83K
89.88%319K
90.57%101K
105.56%74K
315.79%79K
8.33%65K
Other non cash items
153.21%45.94M
158.70%8.48M
105.12%3.61M
7,239.55%31.77M
306.24%2.08M
-4,816.63%-86.34M
-910.63%-14.45M
-15,413.22%-70.43M
-336.70%-445K
-1,581.67%-1.01M
Change In working capital
-223.18%-9.2M
-253.01%-4.04M
-988.86%-3.03M
246.57%2.88M
-236.99%-5.01M
323.96%7.47M
165.19%2.64M
902.94%341K
-60.97%831K
351.89%3.66M
-Change in prepaid assets
-112.59%-1.09M
-73.91%508K
-148.98%-2.69M
-63.04%1.08M
-99.71%14K
669.19%8.66M
660.55%1.95M
60.18%-1.08M
31.28%2.93M
478.04%4.87M
-Change in payables and accrued expense
-579.15%-8.11M
-758.41%-4.54M
-123.68%-337K
185.91%1.8M
-314.51%-5.03M
34.14%-1.19M
116.04%690K
-48.27%1.42M
-2,015.15%-2.09M
-639.63%-1.21M
Cash from discontinued investing activities
Operating cash flow
2.00%-82.44M
-10.62%-24.3M
-4.94%-19.34M
28.24%-16.23M
-6.93%-22.57M
19.48%-84.12M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
Investing cash flow
Cash flow from continuing investing activities
211.03%59.17M
896.12%6.56M
153.44%24.84M
174.07%16.3M
-28.38%11.47M
38.63%-53.3M
-101.03%-824K
-170.38%-46.49M
-20.81%-22.01M
107.46%16.02M
Capital expenditure reported
98.19%-6K
--0
50.00%-1K
--0
96.93%-5K
-31.87%-331K
88.89%-9K
97.14%-2K
-57.00%-157K
---163K
Net PPE purchase and sale
97.68%-6K
25.00%-6K
--0
--0
--0
66.49%-259K
94.37%-8K
--0
125.00%29K
-400.00%-280K
Net intangibles purchase and sale
---83K
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
181.04%359K
870.27%359K
----
----
----
---443K
--37K
----
----
----
Net investment purchase and sale
242.58%66.65M
3,535.84%6.29M
164.42%28.67M
187.83%19.22M
-35.89%12.48M
43.56%-46.75M
-99.78%173K
-166.85%-44.51M
-21.55%-21.88M
109.19%19.46M
Net other investing changes
-40.49%-7.75M
--0
-155.85%-3.83M
---2.91M
66.63%-1M
-83.77%-5.51M
---1.02M
---1.5M
--0
0.00%-3M
Cash from discontinued investing activities
Investing cash flow
211.03%59.17M
897.08%6.56M
153.44%24.84M
174.08%16.3M
-28.39%11.47M
38.63%-53.3M
-101.03%-823K
-170.38%-46.49M
-20.81%-22.01M
107.46%16.02M
Financing cash flow
Cash flow from continuing financing activities
164.32%5.37M
101.82%154K
4.89M
426.00%326K
0
-140.20%-8.36M
-817.68%-8.46M
0
-105.57%-100K
56.06%206K
Net issuance payments of debt
--5M
--0
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
160.98%535K
15,500.00%154K
--55K
--326K
--0
-91.06%205K
-100.81%-1K
--0
--0
56.06%206K
Net other financing activities
98.12%-161K
--0
----
----
----
-396.09%-8.56M
-709.57%-8.46M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
164.32%5.37M
101.82%154K
--4.89M
426.00%326K
--0
-140.20%-8.36M
-817.68%-8.46M
--0
-105.57%-100K
56.06%206K
Net cash flow
Beginning cash position
-76.37%45.03M
-41.22%44.96M
-75.67%34.33M
-81.78%33.87M
-76.37%45.03M
-47.38%190.61M
-46.34%76.49M
67.70%141.09M
49.94%185.89M
-47.38%190.61M
Current changes in cash
87.73%-17.89M
43.73%-17.58M
116.01%10.39M
100.89%400K
-127.19%-11.1M
14.52%-145.77M
-164.26%-31.25M
-212.34%-64.92M
-16.60%-44.72M
97.95%-4.89M
Effect of exchange rate changes
91.53%362K
158.02%123K
-25.47%237K
186.84%66K
-140.25%-64K
116.83%189K
61.52%-212K
-48.79%318K
94.91%-76K
-46.82%159K
End cash Position
-38.92%27.51M
-38.92%27.51M
-41.22%44.96M
-75.67%34.33M
-81.78%33.87M
-76.37%45.03M
-76.37%45.03M
-46.34%76.49M
67.70%141.09M
49.94%185.89M
Free cash flow
2.57%-82.53M
-10.94%-24.38M
-4.93%-19.34M
28.64%-16.23M
-4.75%-22.58M
19.70%-84.71M
28.47%-21.98M
35.49%-18.43M
-2.69%-22.74M
10.35%-21.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.00%-82.44M-10.62%-24.3M-4.94%-19.34M28.24%-16.23M-6.93%-22.57M19.48%-84.12M28.01%-21.96M34.28%-18.43M-3.11%-22.61M11.99%-21.11M
Net income from continuing operations -241.84%-150.05M-103.69%-38.99M-160.66%-26.31M-69.87%-57.37M20.31%-27.38M72.12%-43.9M58.97%-19.14M221.49%43.37M9.96%-33.77M8.53%-34.35M
Operating gains losses -55.86%1.91M21.28%701K-1,828.57%-810K-93.47%126K1.61%1.9M-54.74%4.33M-87.10%578K98.03%-42K-38.62%1.93M-54.26%1.87M
Depreciation and amortization 48.28%473K122.77%225K12.16%83K3.80%82K27.69%83K89.88%319K90.57%101K105.56%74K315.79%79K8.33%65K
Other non cash items 153.21%45.94M158.70%8.48M105.12%3.61M7,239.55%31.77M306.24%2.08M-4,816.63%-86.34M-910.63%-14.45M-15,413.22%-70.43M-336.70%-445K-1,581.67%-1.01M
Change In working capital -223.18%-9.2M-253.01%-4.04M-988.86%-3.03M246.57%2.88M-236.99%-5.01M323.96%7.47M165.19%2.64M902.94%341K-60.97%831K351.89%3.66M
-Change in prepaid assets -112.59%-1.09M-73.91%508K-148.98%-2.69M-63.04%1.08M-99.71%14K669.19%8.66M660.55%1.95M60.18%-1.08M31.28%2.93M478.04%4.87M
-Change in payables and accrued expense -579.15%-8.11M-758.41%-4.54M-123.68%-337K185.91%1.8M-314.51%-5.03M34.14%-1.19M116.04%690K-48.27%1.42M-2,015.15%-2.09M-639.63%-1.21M
Cash from discontinued investing activities
Operating cash flow 2.00%-82.44M-10.62%-24.3M-4.94%-19.34M28.24%-16.23M-6.93%-22.57M19.48%-84.12M28.01%-21.96M34.28%-18.43M-3.11%-22.61M11.99%-21.11M
Investing cash flow
Cash flow from continuing investing activities 211.03%59.17M896.12%6.56M153.44%24.84M174.07%16.3M-28.38%11.47M38.63%-53.3M-101.03%-824K-170.38%-46.49M-20.81%-22.01M107.46%16.02M
Capital expenditure reported 98.19%-6K--050.00%-1K--096.93%-5K-31.87%-331K88.89%-9K97.14%-2K-57.00%-157K---163K
Net PPE purchase and sale 97.68%-6K25.00%-6K--0--0--066.49%-259K94.37%-8K--0125.00%29K-400.00%-280K
Net intangibles purchase and sale ---83K------------------0----------------
Net business purchase and sale 181.04%359K870.27%359K---------------443K--37K------------
Net investment purchase and sale 242.58%66.65M3,535.84%6.29M164.42%28.67M187.83%19.22M-35.89%12.48M43.56%-46.75M-99.78%173K-166.85%-44.51M-21.55%-21.88M109.19%19.46M
Net other investing changes -40.49%-7.75M--0-155.85%-3.83M---2.91M66.63%-1M-83.77%-5.51M---1.02M---1.5M--00.00%-3M
Cash from discontinued investing activities
Investing cash flow 211.03%59.17M897.08%6.56M153.44%24.84M174.08%16.3M-28.39%11.47M38.63%-53.3M-101.03%-823K-170.38%-46.49M-20.81%-22.01M107.46%16.02M
Financing cash flow
Cash flow from continuing financing activities 164.32%5.37M101.82%154K4.89M426.00%326K0-140.20%-8.36M-817.68%-8.46M0-105.57%-100K56.06%206K
Net issuance payments of debt --5M--0--------------0--0------------
Proceeds from stock option exercised by employees 160.98%535K15,500.00%154K--55K--326K--0-91.06%205K-100.81%-1K--0--056.06%206K
Net other financing activities 98.12%-161K--0-------------396.09%-8.56M-709.57%-8.46M--0--------
Cash from discontinued financing activities
Financing cash flow 164.32%5.37M101.82%154K--4.89M426.00%326K--0-140.20%-8.36M-817.68%-8.46M--0-105.57%-100K56.06%206K
Net cash flow
Beginning cash position -76.37%45.03M-41.22%44.96M-75.67%34.33M-81.78%33.87M-76.37%45.03M-47.38%190.61M-46.34%76.49M67.70%141.09M49.94%185.89M-47.38%190.61M
Current changes in cash 87.73%-17.89M43.73%-17.58M116.01%10.39M100.89%400K-127.19%-11.1M14.52%-145.77M-164.26%-31.25M-212.34%-64.92M-16.60%-44.72M97.95%-4.89M
Effect of exchange rate changes 91.53%362K158.02%123K-25.47%237K186.84%66K-140.25%-64K116.83%189K61.52%-212K-48.79%318K94.91%-76K-46.82%159K
End cash Position -38.92%27.51M-38.92%27.51M-41.22%44.96M-75.67%34.33M-81.78%33.87M-76.37%45.03M-76.37%45.03M-46.34%76.49M67.70%141.09M49.94%185.89M
Free cash flow 2.57%-82.53M-10.94%-24.38M-4.93%-19.34M28.64%-16.23M-4.75%-22.58M19.70%-84.71M28.47%-21.98M35.49%-18.43M-2.69%-22.74M10.35%-21.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 70.310
Sample Name
Sample Code
 8.110
Sample Name
Sample Code
 15.120
4
Collegium Pharmaceutical
COLL
27.780
5
Enerpac Tool
EPAC
42.050
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 100.590
Sample Name
Sample Code
 126.570
Sample Name
Sample Code
 599.270
4
Microsoft
MSFT
436.170
5
Alphabet-C
GOOG
166.050
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 2.180
Sample Name
Sample Code
 3.640
Sample Name
Sample Code
 8.200
4
Argo Blockchain
ARBK
0.4151
5
Coinbase
COIN
199.400
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Earnings Season Underway

Earnings season is here. What to know?

- No more -